Content area
Full Text
Acta Neuropathol (2006) 111: 178185
DOI 10.1007/s00401-005-0026-8ORIGINAL PAPERCarmen Navarro Susana Teijeira Carmen Dominguez
Jose M. Fernandez Eloy Rivas Carmen Fachal
Soraya Barrera Carmen Rodriguez Pilar IranzoFabry disease: an ultrastructural comparative study of skin in hemizygous
and heterozygous patientsReceived: 2 August 2005 / Revised: 21 November 2005 / Accepted: 22 November 2005 / Published online: 7 February 2006
Springer-Verlag 2006Abstract Fabry disease is a rare X-linked lysosomal
storage disorder due to alpha galactosidase A deciency,
better known after the advent of a promising treatment,
a periodical enzyme replacement. As other hereditary
X-linked disorders, females have historically been considered non-aected carriers, although they are, actually, clinically and pathologically aected to a variable
degree. Some women are asymptomatic, but the
majority present milder forms of the disease and later
onset. This wide range of disease expression is supposed
to be related to the levels of enzymatic activity, probably
in accordance with a skewing of X inactivation. Lysosomal deposits of ceramide trihexoside have been
repeatedly documented in a wide range of tissues,
including those found in angiokeratoma, the characteristic cutaneous lesion which allowed the denition of
Fabry disease. The aim of this study was to investigate
whether there was any dierence in the amount of dermal lysosomal storage in males and females, thus
accounting for the dierence in clinical severity of both
groups. For that purpose, with electron microscopy and
quantitative methods, we studied the extent of lysosomal
deposits in dermal broblasts of normal-appearing skin
in six females and nine men, enzymatically and genetically proven as to have Fabry disease, and results were
compared. Our results indicate a statistically signicant
dierence between the two groups regarding both the
percentage of dermal broblasts bearing stored material,
and the storage surface occupied in 100 broblasts per
case. We suggest that periodical ultrastructural examination of normal-appearing skin could be an indicator
of the ecacy of enzyme replacement therapy and could
help to evaluate results.Keywords Dermal ultrastructure Fabry disease
Fibroblast Heterozygous women Lysosomal storageIntroductionC. Navarro (&) S. Teijeira E. Rivas C. Fachal S. Barrera
Department of Pathology and Neuropathology,University Hospital (Meixoeiro), Meixoeiro, s/n,36215 Vigo, SpainE-mail: [email protected].: +34-986-811111Fax: +34-986-276416C. DominguezBiochemistry and Molecular Biology Research Center,
Vall dHebron Hospital, Barcelona, SpainJ. M. FernandezDepartment of Clinical Neurophysiology, University Hospital
(Xeral-Cies), Vigo, SpainC. RodriguezDermatology Service, University Hospital...